Treatment of shock associated with myocardial infarction.
D000418:Albumins / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000628:therapy; D003911:Dextrans / Q000627:therapeutic use; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004298:Dopamine / Q000627:therapeutic use; D006355:Heart-Lung Machine; D006801:Humans; D007545:Isoproterenol / Q000627:therapeutic use; D008616:Mephentermine / Q000627:therapeutic use; D008680:Metaraminol / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000628:therapy*; D009638:Norepinephrine / Q000627:therapeutic use; D010643:Phenoxybenzamine / Q000627:therapeutic use; D010646:Phentolamine / Q000627:therapeutic use; D010952:Plasma Substitutes / Q000627:therapeutic use; D012769:Shock / Q000628:therapy*
D000418:Albumins; D003911:Dextrans; D004071:Digitalis Glycosides; D010952:Plasma Substitutes; D010643:Phenoxybenzamine; D008680:Metaraminol; D007545:Isoproterenol; D008616:Mephentermine; D004298:Dopamine; D009638:Norepinephrine; D010646:Phentolamine